{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T15:36:03Z","timestamp":1780932963581,"version":"3.54.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.clbc.2020.08.010","type":"journal-article","created":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T21:12:01Z","timestamp":1599081121000},"page":"e220-e227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0524-8035","authenticated-orcid":false,"given":"Jordan","family":"Ciuro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1523-7804","authenticated-orcid":false,"given":"Alisha","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8604-7728","authenticated-orcid":false,"given":"Jessica","family":"Fritzler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5509-3556","authenticated-orcid":false,"given":"Samira","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2020.08.010_bib7","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.294.15.1925","article-title":"Genetic testing in an ethnically diverse cohort of high-risk women: a comparative analysis of BRCA1 and BRCA2 mutations in American families of European and African ancestry","volume":"294","author":"Nanda","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2020.08.010_bib1","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1056\/NEJMoa1706450","article-title":"Olaparib for metastatic breast cancer in patients with a germline BRCA mutation","volume":"377","author":"Robson","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib2","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1200\/JCO.2006.05.5889","article-title":"Disparities in genetic testing: thinking outside the BRCA box","volume":"24","author":"Hall","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.08.010_bib23","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1001\/jama.2010.1237","article-title":"Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality","volume":"304","author":"Domchek","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2020.08.010_bib26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.3390\/cancers10120524","article-title":"BRCA mutations and breast cancer prevention","volume":"10","author":"Kotsopoulos","year":"2018","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2020.08.010_bib25","first-page":"2109","article-title":"BRCA genes: the role in genome stability, cancer stemness and therapy resistance","volume":"10","author":"Gorodetska","year":"2019","journal-title":"J\u00a0Cancer"},{"key":"10.1016\/j.clbc.2020.08.010_bib27","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1126\/science.1251827","article-title":"Two decades after BRCA: setting paradigms in personalized cancer care and prevention","volume":"343","author":"Couch","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.clbc.2020.08.010_bib3","doi-asserted-by":"crossref","first-page":"8297","DOI":"10.1158\/0008-5472.CAN-06-0503","article-title":"Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years","volume":"66","author":"Malone","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.clbc.2020.08.010_bib4","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.24200","article-title":"BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast\u2013ovarian cancer","volume":"115","author":"Hall","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2020.08.010_bib29","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/ijerph14050486","article-title":"Assessing the racial and ethnic disparities in breast cancer mortality in the United States","volume":"14","author":"Yedjou","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.clbc.2020.08.010_bib5","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1002\/cam4.1120","article-title":"Predictors of BRCA1\/2 genetic testing among black women with breast cancer: a population-based study","volume":"6","author":"Jones","year":"2017","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib18","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2002.20.6.1480","article-title":"Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals","volume":"20","author":"Frank","year":"2002","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.08.010_bib19","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/s004390000290","article-title":"Prevalence of BRCA1 and BRCA2 mutations among clinic-based African American families with breast cancer","volume":"107","author":"Gao","year":"2000","journal-title":"Hum Genet"},{"key":"10.1016\/j.clbc.2020.08.010_bib14","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1097\/GIM.0b013e31815699d0","article-title":"The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention?","volume":"9","author":"Khoury","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib15","first-page":"177","article-title":"Next-generation sequencing for cancer diagnostics: a practical perspective","volume":"32","author":"Meldrum","year":"2011","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.clbc.2020.08.010_bib17","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1056\/NEJMra0907178","article-title":"Genomics and the continuum of cancer care","volume":"364","author":"McDermott","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib16","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1056\/NEJMra012240","article-title":"Genomic medicine\u2014a primer","volume":"347","author":"Guttmacher","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib31","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa1802905","article-title":"Talazoparib in patients with advanced breast cancer and a germline BRCA mutation","volume":"379","author":"Litton","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib12","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/nrclinonc.2010.166","article-title":"BRCA mutations in the management of breast cancer: the state of the art","volume":"7","author":"Narod","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.clbc.2020.08.010_bib13","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1200\/JCO.2009.25.0712","article-title":"Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women","volume":"28","author":"Metcalfe","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.08.010_bib20","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jama.279.12.915","article-title":"Frequency of breast cancer attributable to BRCA1 in a population-based series of American women","volume":"279","author":"Newman","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.clbc.2020.08.010_bib21","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s004390051059","article-title":"BRCA1 mutations in African Americans","volume":"105","author":"Panguluri","year":"1999","journal-title":"Hum Genet"},{"key":"10.1016\/j.clbc.2020.08.010_bib9","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1200\/JCO.2018.78.3977","article-title":"Inherited breast cancer in Nigerian women","volume":"36","author":"Zheng","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2020.08.010_bib30","doi-asserted-by":"crossref","first-page":"539","DOI":"10.2105\/AJPH.92.4.539","article-title":"Impact of breast cancer on African American women: priority areas for research in the next decade","volume":"92","author":"Jones","year":"2002","journal-title":"Am J Public Health"},{"key":"10.1016\/j.clbc.2020.08.010_bib11","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/gim.2017.231","article-title":"Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutational carriers","volume":"20","author":"Tuffaha","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/ajmg.a.10928","article-title":"Early use of clinical BRCA1\/2 testing: associations with race and breast cancer risk","volume":"117","author":"Armstrong","year":"2003","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.clbc.2020.08.010_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41525-019-0096-5","article-title":"Impact of free cancer predisposition cascade genetic testing on uptake in Singapore","volume":"4","author":"Courtney","year":"2019","journal-title":"NPJ Genom Med"},{"key":"10.1016\/j.clbc.2020.08.010_bib22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1377\/hlthaff.2015.1476","article-title":"Using genetic technologies to reduce, rather than widen, health disparities","volume":"35","author":"Smith","year":"2016","journal-title":"Health Aff (Milwood)"},{"key":"10.1016\/j.clbc.2020.08.010_bib24","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.amjsurg.2009.07.003","article-title":"Disparities in BRCA testing: when insurance coverage is not a barrier","volume":"198","author":"Olaya","year":"2009","journal-title":"Am J Surg"},{"key":"10.1016\/j.clbc.2020.08.010_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.amepre.2016.03.016","article-title":"Use of cancer genetics services in African-American young breast cancer survivors","volume":"51","author":"Jones","year":"2016","journal-title":"Am J Prev Med"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920302159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820920302159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:20:04Z","timestamp":1761513604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820920302159"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1526820920302159"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2020.08.010","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2020.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}